Editor: Atta-ur-Rahman FRS

Frontiers in Clinical Drug Research-Hematology

Volume 2

eBook: US $89 Special Offer (PDF + Printed Copy): US $163
Printed Copy: US $119
Library License: US $356
ISSN: 2352-3239 (Print)
ISBN: 978-1-68108-182-3 (Print)
ISBN: 978-1-68108-181-6 (Online)
Year of Publication: 2016
DOI: 10.2174/97816810818161160201

Introduction

Frontiers in Clinical Drug Research – Hematology is an eBook series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of hematological disorders. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs employed in the treatment of anemias, coagulopathies, vascular diseases and hematological malignancies. Reviews in this series also include research on specific antibody targets, therapeutic methods, genetic hemoglobinopathies and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Hematology is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of hematology, oncology and vascular pharmacology.

The second volume of this series features 5 chapters that cover a variety of topics including:

  • - Chronic myeloid leukemia
  • - ispecific and multivalent antibodies
  • - Natural Killer cells therapy for bone marrow transplantation
  • - Nanoparticles in health and disease
  • - Monoclonal antibody therapy for lymphoma

Contributors

Editor(s):
Atta-ur-Rahman FRS
Kings College
University of Cambridge
UK




Contributor(s):
Alvaro Urbano-Ispizua
Department of Hematology, Hospital Clinic, IDIBAPS
Barcelona
Spain
/
Josep Carreras Leukaemia Research Institute
Barcelona
Spain


Arvind Shukla
School of Biotechnology and Bioinformatics, D.Y. Patil University
Plot No.50, Sector- 15, C.B.D. Belapur, Navi Mumbai, 400614,
Maharastra
India


Beatriz Martín-Antonio
Department of Hematology, Hospital Clinic, IDIBAPS
Barcelona
Spain
/
Josep Carreras Leukaemia Research Institute
Barcelona
Spain


Carla Di Stefano
Department of Hematology, "Tor Vergata" University, Viale Oxford 81, 00133
Rome
Italy


Ciril Rozman
University of Barcelona
Barcelona
Spain
/
Josep Carreras Leukaemia Research Institute
Barcelona
Spain


Colin Phipps
Department of Hematology, Singapore General Hospital
Singapore


Dagmar Jirova
Center of Toxicology and Health Safety
National Institute of Public Health, Srobarova 48, 100 42
Instituto Nacional de Câncer (INCA)
Prague, Czech Republic


Gabriella Marfe
Department of Biochemistry and Biophysics
Second University of Naples, via De Crecchio 7
Naples 80138
Italy


Giovanna Mirone
Department of Medical Oncology B
Regina Elena National Cancer Institute, via Elio Chianesi 53, 00144
Rome, Italy


Juergen Hess
Lerchenstraße 3, D-85368
Moosburg
Germany


Kristina Kejlova
Center of Toxicology and Health Safety
National Institute of Public Health, Srobarova 48, 100 42
Prague
Czech Republic


Marketa Dvorakova
Center of Toxicology and Health Safety
National Institute of Public Health, Srobarova 48, 100 42
Prague
Czech Republic


Michael Stanglmaier
Lerchenstraße 3, D-85368
Moosburg
Germany


Nuria Martínez-Cibrian
Department of Hematology, Hospital Clinic, IDIBAPS
Barcelona
Spain
/
Josep Carreras Leukaemia Research Institute
Barcelona
Spain


Stanislav Janousek
Center of Toxicology and Health Safety
National Institute of Public Health, Srobarova 48, 100 42
Prague
Czech Republic




RELATED BOOKS

.Frontiers in Clinical Drug Research-Hematology.
.Frontiers in Clinical Drug Research-Hematology.
.The Spleen.